As of 2026-10-07, the EV/EBITDA ratio of Precigen Inc (PGEN) is -18.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PGEN's latest enterprise value is 2,769.20 mil USD. PGEN's TTM EBITDA according to its financial statements is -146.49 mil USD. Dividing these 2 quantities gives us the above PGEN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 15.3x | 12.6x |
| Forward P/E multiples | 10.2x - 17.2x | 14.4x |
| Fair Price | (4.39) - (6.50) | (5.77) |
| Upside | -158.2% - -186.1% | -176.5% |
| Date | EV/EBITDA |
| 2026-10-06 | -18.90 |
| 2026-10-05 | -19.37 |
| 2026-10-02 | -21.31 |
| 2026-10-01 | -20.51 |
| 2026-09-30 | -21.36 |
| 2026-09-29 | -20.12 |
| 2026-09-28 | -19.54 |
| 2026-09-25 | -19.39 |
| 2026-09-24 | -19.27 |
| 2026-09-23 | -18.64 |
| 2026-09-22 | -19.73 |
| 2026-09-21 | -19.27 |
| 2026-09-18 | -19.46 |
| 2026-09-17 | -19.68 |
| 2026-09-16 | -18.62 |
| 2026-09-15 | -17.57 |
| 2026-09-14 | -17.20 |
| 2026-09-11 | -17.20 |
| 2026-09-10 | -16.79 |
| 2026-09-09 | -17.08 |
| 2026-09-08 | -17.25 |
| 2026-09-04 | -17.81 |
| 2026-09-03 | -17.91 |
| 2026-09-02 | -17.59 |
| 2026-09-01 | -17.22 |
| 2026-08-31 | -17.40 |
| 2026-08-28 | -17.44 |
| 2026-08-27 | -18.03 |
| 2026-08-26 | -18.59 |
| 2026-08-25 | -18.25 |
| 2026-08-24 | -17.98 |
| 2026-08-21 | -18.05 |
| 2026-08-20 | -18.64 |
| 2026-08-19 | -17.95 |
| 2026-08-18 | -16.96 |
| 2026-08-17 | -16.47 |
| 2026-08-14 | -15.38 |
| 2026-08-13 | -16.32 |
| 2026-08-12 | -17.20 |
| 2026-08-11 | -17.22 |
| 2026-08-10 | -17.57 |
| 2026-08-07 | -18.13 |
| 2026-08-06 | -17.35 |
| 2026-08-05 | -17.30 |
| 2026-08-04 | -16.42 |
| 2026-08-03 | -16.62 |
| 2026-07-31 | -15.79 |
| 2026-07-30 | -14.99 |
| 2026-07-29 | -13.79 |
| 2026-07-28 | -13.99 |